Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NEC Corp.

Latest From NEC Corp.

NEC Moves Beyond IT Tools As It Pursues AI-Driven Drug Discovery Initiative

In an exclusive interview, Japanese tech giant NEC tells Scrip it is aiming for much more than the provision of IT tools in its AI-assisted Drug Discovery Initiative, hoping also to progress assets deriving from cutting-edge technology research. 

Artificial Intelligence Business Strategies

Xeotron Corp.

Xeotron Corp. employs light activation, digital photolithography, and parallel microfluidics in its biochip making process. The company claims that its flexible platform technology will produce DNA, protein and peptide chips at a faster rate and lower cost than its competitors.
BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • NEC Corp.
  • Senior Management
  • Akinobu Kanasugi, Pres.
  • Contact Info
  • NEC Corp.
    Phone: (81) 03-3454-1111
    7-1, Shiba 5-chome
    Minato-ku, NY 108-8001
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register